Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 133Stomach Neoplasms 107Carcinoma, Hepatocellular 73Rectal Neoplasms 64Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Neoplasms 28Neoplasm Metastasis 20Esophageal Squamous Cell Carcinoma 20Gastrointestinal Neoplasms 19Cholangiocarcinoma 14Liver Neoplasms 13Breast Neoplasms 13Barrett Esophagus 9Lung Neoplasms 8Adenoma 8Motor Activity 7Liver Cirrhosis 7Digestive System Neoplasms 7Colonic Polyps 7Adenomatous Polyposis Coli 7Biliary Tract Neoplasms 6Anastomotic Leak 6Sarcopenia 5Inflammatory Bowel Diseases 5Hypertension, Portal 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4

Interventions

Methods 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Pancreatic Cancer Liver Metastases × Gastrointestinal × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡